ACUTAAS — AI Stock Dissection

AI Stock Dissection

Fetching the live quote…Computing price structure…Running the AI dissection…Writing the executive briefing…Scoring risks & catalysts…

Sensai

Reading the tape…Pulling live market data…Setting the scene…

AI Stock Dissection

ACUTAASLive

ACUTAAS

Mr. Nareshkumar Ramjibhai Patel · Surat, India

₹3,306.20

▲+0.26%

AcutAAS is trading near the upper third of its 52‑week range on strong revenue growth and high margins, but the lofty 94× P/E suggests the market has already priced in much of the upside.

Exchange

NSI

Currency

INR

Day range

₹3,265.00 – ₹3,390.00

52-week range

₹1,125.00 – ₹3,740.00

Sector

Basic Materials

Industry

Specialty Chemicals

AI investment rating

AI analysis

Accumulate

70% confidence

Given the current price of ₹3,306 versus a 52‑week high of ₹3,740 and low of ₹1,125, the stock appears fully valued to slightly expensive; a fair‑value band would likely sit in the low‑₹3,000s if growth normalises.

Position in 52-week range

Live

52w low83%52w high

11.6% below the 1-year high · trend up

Fundamentals

Live

Market cap

Hedge-fund memo

Executive AI briefing

AI analysis

Today

Price up 0.26% to ₹3,306 on modest volume (353k shares), holding above the day‑low of ₹3,265.

This week

No weekly data supplied; recent price action suggests consolidation near the 52‑week high.

This month

No monthly data supplied; the stock has rallied sharply from the 52‑week low of ₹1,125 over the past year.

Bull thesis

59% YoY revenue growth with 26% net margin indicates scalable profitability.
Very low debt‑to‑equity (2%) provides financial flexibility for capacity expansion.

Bear thesis

P/E of 94× leaves little margin for any growth deceleration.
Institutional ownership only 27.6% may limit sustained buying pressure.

News & sentiment

What the press is saying

24 headlines · live

Bullish

24 headlines · 13 outlets · 7d

Tone · daily average

07-2407-28

+70
Acutaas Chemicals Q1 Results: Net profit up 70% to ₹74.9 crore

Smart money

Who owns it

Live

Ownership split

Insiders / promoters38.31%

Institutions (FII/DII/MF)27.61%

Public & others34.08%

Top institutional holders

Not listed

Named holders aren't published for this listing (common for Indian stocks). The split at left is live.

Financial health

The numbers

Live

Profitability

Return on equity—
Return on assets—
Profit margin26.42%
Operating margin31.32%
Gross margin58.42%

Growth

Revenue (TTM)14.62B
Revenue growth59.10%
Earnings growth67.10%

Balance sheet

Debt / equity2.08%

07b

Financial statements

Multi-year trend

Live

Line item

2023202420252026

Revenue

₹6.2B

₹7.2B

₹10.1B

₹13.4B

Gross profit

₹0

Earnings intelligence

Beat history

Live

Beat estimates in 2 of 4 recent quarters (EPS actual vs. consensus).

2026-06-30Miss

9.04 vs 9.56667

-5.51% surprise

2026-03-31Beat

16.04 vs 13.05

22.91% surprise

2025-12-31Beat

13.1 vs 9.05

44.75% surprise

Competitive landscape

Versus peers

Live

Company	Market cap	P/E	ROE	Op. margin	Rev. growth
ACUTAASACUTAAS	264.75B	92.26	—	31.32%	59.10%
CLEANClean Science and Technology Limited	77.49B	33.75	15.31%	30.07%	-5.50%
ANURASAnupam Rasayan India Ltd	137.85B	78.52	5.76%

Technical intelligence

Price structure

Live

ACUTAASdaily · candles

Hover the chart for that day's open / high / low / close, volume and RSI.

Volume

RSI (14) · 70 overbought / 30 oversold

MACD (12,26,9) · MACD vs signal

Candlesticks, volume, RSI and MACD from 500sessions of real Yahoo daily data. Moving averages use full history, so they're accurate at the left edge. Support / resistance are the 52-week low / high. Educational — technical signals are not buy or sell calls.

Risk intelligence

What could go wrong

AI analysis

Raw‑material price spikes (e.g., petrochemical feedstocks) eroding margins

P: MediumImpact: High

Mitigation: Long‑term supply contracts and hedging program

Regulatory changes in environmental compliance increasing capex

P: LowImpact: Medium

Mitigation: Proactive investment in green chemistry and waste‑reduction tech

Key customer loss or contract renegotiation

P: MediumImpact: High

Mitigation: Diversify customer base across geographies and end‑markets

Business intelligence

Moat · supply chain · M&A

AI analysis

Competitive moat

Proprietary low‑cost, high‑yield synthesis routes protected by patents and deep customer integration create switching costs for OEMs.

Supply chain

Upstream (inputs / suppliers)

Petrochemical feedstock suppliers (e.g., naphtha, ethylene)Specialty catalyst vendorsUtilities (steam, power) providers

↓

Downstream (customers / markets)

Automotive OEMs (coatings, adhesives)Electronics manufacturers (encapsulants, dielectrics)Consumer goods firms (high‑performance additives)

M&A / strategic moves

No publicly disclosed acquisitions, divestitures, JVs or major strategic moves in the last 12 months.

Catalyst calendar

What to watch next

AI analysis

Next quarter (Q2 FY25)High impact
Earnings release with FY25 revenue guidance
H2 FY25Medium impact
Commissioning of new specialty polymer plant
FY25Medium impact
Potential strategic partnership or licensing deal

Thesis builder

Bull / base / bear

AI analysis

Bull case

Sustained >50% revenue growth and margin expansion drive earnings to justify a premium multiple, pushing the stock toward ₹4,000.

Base case

Growth moderates to 20‑25% YoY; valuation compresses to 40‑50× P/E, implying a price range of ₹2,800‑₹3,200.

Bear case

Revenue growth stalls below 15% and margins contract, causing multiple de‑rating to 20‑30× and a drop toward ₹2,000.

Time horizon

12‑18 months

Est. CAGR

15‑25%

Entry (qual.)

Buy on pullbacks to the ₹3,000‑₹3,100 zone with a 5‑10% position size.

Exit (qual.)

Trim above ₹3,800 or if quarterly growth guidance falls below 20%.

Overall conviction 70%

Knowledge graph

How it all connects

Entity graph

Executives & sector are live; peers are clickable → their dissection. Institutional holders shown where the exchange publishes them.

Portfolio impact

Does it fit your book?

Your holdings

Enter tickers + weights, then see how ACUTAAS fits.

Enter your portfolio and hit “Analyze fit” to see ACUTAAS's correlation, diversification benefit, and concentration impact.

Scenario simulator

Stress the thesis

Simulate a macro shock and see the illustrative impact:

Tailwind for tech & enablers.

Illustrative impact

Medium prob.

Revenue+6%

EPS+9%

Valuation+14%

Directional illustration only — not modelled on this company's actuals. A real simulator needs company financials.

Explain like…

Tailored explanations

Re-explain ACUTAAS for a different audience:

Pick a persona to get a tailored explanation.

Important disclaimer

Sensai publishes educational market commentary, not investment advice. We are not SEBI-registered investment advisers or research analysts, and nothing here is a recommendation to buy, sell, or hold any security.

Live prices, index levels, and other market data are pulled from third-party feeds, may be delayed, and can be inaccurate or unavailable. Do not rely on them for trading decisions.

Investing in equities carries risk, including the loss of principal. Always do your own research and consider consulting a SEBI-registered adviser before making any investment decision.

Position in 52-week range

Fundamentals

Executive AI briefing

What the press is saying

Who owns it

Ownership split

Top institutional holders

The numbers

Multi-year trend

Beat history

Versus peers

Price structure

What could go wrong

Moat · supply chain · M&A

What to watch next

Bull / base / bear

How it all connects

Entity graph

Does it fit your book?

Your holdings

Stress the thesis

Tailored explanations

Important disclaimer

Levels & position

Oscillators & averages